Research output per year
Research output per year
Personal profile
Public Profile
Dr Ross is a clinician researcher with expertise in all aspects of chronic myeloid leukaemia (CML) and myeloproliferative neoplasms (MPN) from laboratory diagnosis to treatment, clinical trials, and biology. He is a Consultant Haematologist in SA Pathology with clinical appointments at the Royal Adelaide Hospital and Flinders Medical Centre in Adelaide, Australia. He was awarded a PhD (December 2009) for his thesis on minimal residual disease in CML in conjunction with leading a pioneering clinical trial of treatment-free remission for CML patients in deep molecular remission and associated correlative science projects. His aim is to provide a world-leading academic clinical service for people with CML and MPN, integrated with clinical and translational research.
Education/Academic qualification
PhD, Minimal residual disease in chronic myeloid leukaemia after imatinib treatment, University of Adelaide
Award Date: 15 Dec 2009
Fellowship of the Royal Australasian College of Physicians
Award Date: 1 Jan 2005
Fellowship of the Royal College of Pathologists of Australia
Award Date: 1 Jan 2005
MB BS, University of Adelaide
Award Date: 31 Mar 1996
External positions
Senior Consultant Haematologist, SA Pathology
Keywords
- Myeloid neoplasms
- Chronic Myeloid Leukaemia
- Genetics
- Clinical Trials
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation
Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J. Y., Paik, J. Y., Lee, Y., Siegel, D., Ross, D., Han, B. W., Nguyen, T. K. Y., Christov, C., Kang, H. J., Dicato, M. & Diederich, M., Dec 2024, In: Biomarker Research. 12, 1, 47.Research output: Contribution to journal › Article › peer-review
Open Access -
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies
Campbell, A., Teh, B., Mulligan, S., Ross, D. M., Weinkove, R., Gilroy, N., Gangatharan, S., Prince, H. M., Szer, J., Trotman, J., Lane, S., Dickinson, M., Quach, H., Enjeti, A. K., Ku, M., Gregory, G., Hapgood, G., Ho, P. J., Cochrane, T., Cheah, C., & 8 others, Feb 2024, In: Internal Medicine Journal. 54, 2, p. 328-336 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax
Nguyen, T. M., Joyce, P., Ross, D. M., Bremmell, K., Jambhrunkar, M., Wong, S. S. & Prestidge, C. A., Feb 2024, In: Pharmaceutics. 16, 2, 209.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies
Hudgens, S., Verstovsek, S., Floden, L., Harrison, C. N., Palmer, J., Gupta, V., McLornan, D., McMullin, M. F., Kiladjian, J. J., Foltz, L., Platzbecker, U., Fox, M. L., Mead, A. J., Ross, D. M., Oh, S. T., Perkins, A. A., Leahy, M. F., Deheshi, S., Donahue, R., Klencke, B. J., & 1 others, 2024, (Accepted/In press) In: Value in Health.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry
Ng, W. Y., Erber, W. N., Grigg, A., Dunne, K., Perkins, A., Forsyth, C. & Ross, D. M., Feb 2024, In: Pathology. 56, 1, p. 75-80 6 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)